Methodological issues for using a common data model (CDM) of COVID-19 vaccine uptake and important adverse events of interest (AEIs): the Data and Connectivity COVID-19 Vaccines Pharmacovigilance (DaC-VaP) United Kingdom feasibility study. (Preprint)
Date first appeared online 08/03/2022
DOI 10.2196/preprints.37821
Authors Akbari A., Bedston S., Lyons R., Owen R.
Journal Name JMIR Formative Research
Volume

Documents